QSC GLP1 in AsiaGLP-1 Research Compounds — Research-Grade · ≥99% Purity · COA · Free SG/TH/VN Domestic
QSC Peptides ships research-grade GLP-1 receptor agonist compounds directly to Asia from the Singapore · Thailand · Vietnam warehouse — meaning domestic delivery, no customs delays, and free standard shipping on all orders. Every compound is ≥99% purity verified with Certificate of Analysis (COA).
QSC Peptides≥99% Purity VerifiedCOA Every OrderFree SG/TH/VN DomesticSingapore · Thailand · Vietnam Stock8 Warehouse Regions
// Shipping & Availability — Asia
QSC GLP1 Ships to Asia
🌏 Asia Shipping: QSC Peptides operates domestic warehouses in Singapore, Thailand, and Vietnam — serving customers across Southeast and East Asia with domestic shipping rates and speeds.
Research Use Notice: Research compounds sold for in vitro research purposes only. Compliance with applicable national regulations in each country required.
Why Order from QSC Peptides in Asia?
Domestic warehouse: Singapore · Thailand · Vietnam — no international customs or import delays
≥99% purity verified by third-party analysis on every compound
COA on every order — Certificate of Analysis confirming compound identity and purity
Free standard shipping — Free SG/TH/VN Domestic with no minimum order
QSCTrack tracking — real-time order tracking at qscpeptide.com/track-order/
Full research compound catalog — all 4 compounds in stock
QSC Peptides Global Warehouse Network
Region
Status
🇺🇸 USA
✓ Domestic
🇪🇺 EU
✓ Domestic
🇬🇧 UK
✓ Domestic
🇨🇦 Canada
✓ Domestic
🇦🇺 Australia
✓ Domestic
🇸🇬 Singapore
⭐ Your Region — Domestic
🇹🇭 Thailand
⭐ Your Region — Domestic
🇻🇳 Vietnam
⭐ Your Region — Domestic
// Available in Asia
All QSC GLP1 Compounds — Available in Asia
All compounds below are in stock in the Singapore · Thailand · Vietnam warehouse and available for research orders in Asia.
Comprehensive Q&A covering QSC GLP1 products, shipping to Asia, compound pharmacology, purity standards, and ordering from QSC Peptides.
QSC GLP1 (qscglp1.com) is the dedicated research reference and purchasing guide for QSC Peptides GLP-1 receptor agonist compounds — Semaglutide, Tirzepatide, Retatrutide (LY3437943), and Cagrilintide/CagriSema blends.
QSC Peptides stocks: Semaglutide (10mg, 15mg vials), Tirzepatide (15mg, 20mg, 30mg vials), Retatrutide/LY3437943 (5mg–60mg vials), and Cagrilintide+Semaglutide CagriSema blend (10mg vials). All ≥99% purity with COA.
Retatrutide (LY3437943) is Eli Lilly's triple GLP-1R/GIPR/GCGR agonist. Phase 2 clinical research (NEJM 2023) showed approximately 24–26% average body weight reduction at 48 weeks — the highest reported for any GLP-1 class compound. QSC Peptides offers 5mg to 60mg vials.
CagriSema is a pre-blended combination of Cagrilintide (long-acting amylin analog, AMYR1/3 agonist) and Semaglutide (GLP-1R agonist). Phase 2/3 data shows ~22–25% weight reduction. QSC Peptides offers 10mg (5mg+5mg) vials.
All QSC Peptides GLP-1 compounds are ≥99% purity verified by third-party analysis, with Certificate of Analysis (COA) provided on every order.
GLP-1 is an incretin hormone secreted by intestinal L-cells in response to nutrients. It binds GLP-1R — a class B GPCR — to drive glucose-dependent insulin secretion, appetite suppression via hypothalamic circuits, gastric emptying delay, and β-cell preservation. Native GLP-1 has a ~2-minute plasma half-life; synthetic analogs extend this to days via albumin binding.
Semaglutide is a GLP-1R monoagonist. Tirzepatide is a dual GIP+GLP-1R co-agonist (twincretin), adding GIPR activation which provides insulin sensitization via adipocyte fat oxidation and synergistic GLP-1R amplification — driving ~5–7% greater weight reduction than semaglutide alone.
GCGR (glucagon receptor) agonism in Retatrutide adds energy expenditure increase via UCP1-mediated brown adipose thermogenesis, hepatic fat oxidation (NAFLD research), and direct lipolysis — effects that GLP-1R and GIPR agonism cannot replicate, explaining Retatrutide's superior ~24–26% weight reduction.
Jastreboff AM et al., New England Journal of Medicine, 2023 — Phase 2 randomized controlled trial of Retatrutide (LY3437943) in obesity. The 12mg arm showed ~24% average weight reduction at 48 weeks, with approximately 100% of participants achieving ≥5% weight loss and ~83% achieving ≥15%.
Ozempic and Wegovy are brand names for semaglutide manufactured by Novo Nordisk for therapeutic use. QSC Peptides Semaglutide is research-grade semaglutide for in vitro research purposes only — not for human consumption or therapeutic use.
Mounjaro and Zepbound are brand names for tirzepatide by Eli Lilly for therapeutic use. QSC Peptides Tirzepatide is research-grade for in vitro research purposes only.
Semaglutide has approximately a 7-day plasma half-life via C18 fatty acid-mediated albumin binding. This makes it suitable for once-weekly research protocols requiring stable GLP-1R activation.
No. All QSC Peptides products are strictly for in vitro research purposes only. Not for human consumption, therapeutic, veterinary, or diagnostic use. Not for sale to individuals under 18.
QSC Peptides maintains domestic warehouses in the USA, EU, UK, Canada, Australia, Singapore, Thailand, and Vietnam — enabling domestic shipping in 8 regions worldwide with free standard shipping on all orders.
Yes. QSC Peptides operates three domestic Asian warehouses: Singapore, Thailand, and Vietnam. Customers in Southeast Asia and broader Asia can order with domestic shipping from the nearest warehouse.
Yes. QSC Peptides stocks a Singapore domestic warehouse (SG domestic), enabling domestic shipping within Singapore with no international customs delays.
Yes. QSC Peptides operates a Thailand domestic warehouse (TH domestic) for domestic Thai orders.
Yes. QSC Peptides operates a Vietnam domestic warehouse (VN domestic) for domestic Vietnamese orders.
QSC Peptides accepts multiple payment methods. Cryptocurrency is widely accepted. Visit qscpeptide.com for current payment options available in your region.